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ABSTRACTS(115[50.3] mg vs 176.5[103.2] mg, p<0.01). There was no difference in any
of the other outcome measures.
Conclusion: Intraoperative inﬁltration gives superior pain relief over the
ﬁrst 24 hours following primary TKR, compared to single shot femoral
nerve block. Furthermore, it is also superior in minimising postoperative
opiate use.ASIT MEDICAL STUDENT PRIZE: 0761: THE EFFECT OF LATERALITY ON
SURGICAL ABILITY AND A COMPARISON OF LAPAROSCOPIC SIMULATOR
ABILITY WITH THE VALIDATED RAF FLYING APTITUDE TEST
James Youngs 1, Hyunmi Park 2, Charles Maxwell-Armstrong 2. 1University
of Nottingham, Nottingham, UK; 2Queen's Medical Centre, Nottingham, UK.
Aims: Laterality should not be thought of as simply as right or left handed,
but as a scale from single hand dominant to ambidextrous. There is
currently no aptitude test for surgical selection. This study used the vali-
dated RAF ﬂying aptitude test, and a measure of laterality, to see if they
correlated to simulator performance.
Methods: 23 junior doctors completed a questionnaire to give a measure
of laterality, which was compared to performance on 4 laparoscopic box
trainer tasks.13 junior doctors who had completed the RAF ﬂying aptitude
test performed 2 tasks on a virtual reality laparoscopy simulator.
Results: The laterality quotient showed a signiﬁcant quadratic relationship
to total time on the box trainer (p¼0.006), the R square value showing that
30% of the result could be accounted for by laterality. The ﬂying aptitude
test showed a signiﬁcant relationship (p¼0.01) with total time to complete
the tasks on the simulator.
Conclusions: The people who were more ambidextrous completed the
tasks faster, whereas those who preferred one hand were slower, a method
of teaching trainees to become more ambidextrous would help to improve
performance. The aptitude test was able to predict those who would
perform fastest on the simulator.ASIT MEDICAL STUDENT PRIZE: 1092: AN AFFORDABLE, OBJECTIVE
PERI-OPERATIVE ASSESSMENT TOOL FOR KNEE ARTHROPLASTY
Richard Mark Kwasnicki 1, Raza Ali 1, Stevan James Jordan 2, Louis Atallah 1,
Gareth Jones 2, Ara Darzi 1, Guang-Zhong Yang 1. 1Hamlyn Centre, Institute of
Global Health Innovation, Imperial College London, London, UK; 2 Imperial
College Healthcare NHS Trust, London, UK.
Introduction: Indications for total knee arthroplasty (tka) are largely
based on subjective patient data. The post-operative period lacks per-
sonalised rehabilitation strategies and active follow-up, resulting in sub-
optimal patient outcomes. We investigated the feasibility of using a low-
cost, ear-worn accelerometer (e-ar, imperial college london) to conduct
objective, home-based mobility assessments in the peri-operative setting.
Methods: Fourteen patients on the waiting list for tka, and 15 healthy
subjects, were recruited. Pre-operatively, and at 1, 3, 6, 12 and 24 weeks
post-operatively, subjects completed a short-form health survey (sf-36), a
series of activities of daily living (adl), and underwent knee examination.
During the adl, objective motion data was collected using an ear-worn
sensor. Features extracted from sensor data were embedded in manifold
space to assess patient performance.
Results: Using sensor data, subjects were correctly classiﬁed into their
peri-operative stage with 89% accuracy. Calculation of average class dif-
ferences from the healthy group cluster allowed functional recovery of
individual subjects to be proﬁled, including the detection of complications.
Conclusions: We demonstrate a resource-sparing, objective method of
assessing mobility in the community setting. This could be used to reﬁne
surgical indications, and facilitate regular, remote follow-up, with the
potential to improve the quality of service.
ASIT MEDICAL STUDENT PRIZE: 1483: THE REGENERATIVE POTENTIAL
OF FULLY-DEGUMMED SILK CONDUITS IN PERIPHERAL NERVE INJURY
REPAIR COMPARED TO THE CURRENT ‘GOLD STANDARD’ OF AUTOLO-
GOUS GRAFT REPAIR
Muzzammil Hussain, Wenlong Huang, John Priestley. Barts and The London
Shool of Medicine and Dentistry, Queen Mary University, London, UK.
Introduction: Peripheral nerve injury is a major cause of morbidity. The
‘gold standard’ to treat such injuries is autologous graft repair. This method
risks painful neuroma formation and the incomplete recovery of the
resected nerve. Alternative repair strategies do exist with variable degreesof success. Therefore, a novel fully-degummed ‘silk worm’ ﬁbroin based
Spiderex nerve tube has been developed.
Methods: 12 female Sprague-Dawley rats, Surgical excision of grafts after 8
weeks, Tissue processing, Immuno-histochemistry, Confocal microscopy
and Quantitative analysis.
Results: Axonal regeneration using the Spiderex tube, in the mid-graft
section was comparable to that in the autologous graft (p>0.05) mid-
section with greater regeneration in the distal-section of the nerve
(p<0.01). Overall Schwan cell support was greater in the Spiderex nerve
tube (p<0.05) as compared to the autologous graft. Macrophage responses
were similar at the distal-ends in both the Spiderex tube and autologous
graft treated nerves (p>0.05) but higher at the Spiderex tube, at mid-
graft level compared to the autologous graft mid-section (p<0.05).
Conclusion: The novel Spiderex silk conduit is a suitable alternative for
clinical use. Sacriﬁcing animals beyond 8 weeks may demonstrate superior
nerve regenerative potential of Spiderex tubes. Translation to functional
recovery will be explored further in future studies.SARS ACADEMIC AND RESEARCH PRIZE: 0073: SARS/ASIT ACADEMIC &
RESEARCH SURGERY PRIZE WINNER: AN IN VIVO STUDY OF BIOACTIVE
MULTILAYERED SCAFFOLDS FOR REGENERATION AND REPAIR OF
OSTEOCHONDRAL DEFECTS
Ashwanth Ramesh 1, Tanya Levingstone 1, John M. O'Byrne 3,
Fergal J. O'Brien 2. 1 Tissue Engineering Research Group, Royal College of
Surgeons in Ireland, Dublin, Ireland; 2 Trinity Centre for Bioengineering,
Trinity College Dublin, Dublin, Ireland; 3 The Dept. of Orthopaedic Surgery,
Cappagh National Orthopaedic Hospital, Dublin, Ireland.
Aim: This study aims to assess the regenerative capacity of ChondroColl
(WO2010/084481) ina largeanimalmodel. ChondroColl is anovelmultilayered
scaffold developed in our lab to treat osteochondral defects in the knee joint.
Method: In vivo assessment was carried out by creating a bilateral
6mmx6mm defect in the medial femoral and lateral trochlear ridge per
joint of a caprine model. Both defects in one joint were implanted with
ChondroColl, while the defects in the other joint were left empty, acting as
controls. Initially in a 6 week pilot study was carried out. This was followed
by a long term study at 3months, 6months and 1year. The repair was
assessed by micro CT analysis and histological staining of the samples.
Results: The 6 week and 3 month study showed good scaffold retention
and repair of subchondral bone and generation of hyaline like cartilage.
The 6month and 1 year study are ongoing.
Conclusion: Positive results to date show that ChondroColl to be a
promising method for cartilage repair and regeneration. It negates the
need for other biological agents such as genes, stem cells and growth
factors by stimulating the native tissues repair mechanism from the sur-
rounding bone and cartilage.SARS ACADEMIC AND RESEARCH PRIZE: 0617: BLOCKING EXPRESSION
OF THE TUMOUR SUPPRESSOR GENE, P63 INHIBITS IN-VIVO CARCINO-
GENESIS IN PROSTATE CANCER
Ram Beekharry 1, Willem Bansema 1, Paul Berry 1, Hannah Walker 1,
Amanda Nicholl 3, Anne Collins 1, Matthew Simms 2, Norman Maitland 1.
1Department of Biology, University of York, York, UK; 2Department of
Urology, Castle Hill Hospital, Cottingham, UK; 3 Procure Therapeutics, York, UK.
Introduction: Tumour protein p63 is a member of the p53 family of
transcription factors. In normal prostate, p63 is expressed solely in the
basal epithelial cells and has been associated with both gland
development.
Methods: Using a short hairpin RNA (shRNA) system, p63 expression was
knocked down in PC3 cells to obtain stable PC3 TP63- cells clones. Elimi-
nation of p63 expression was measured by qRT-PCR. To test the effects on
tumour induction, two groups of immuno-compromised male mice (six
weeks old, n¼10) were injected subcutaneously into both ﬂanks with
increasing numbers (range 15-1.5x105) of PC3 TP63 or PC3-2V cells
(expressing a non-functional, scrambled ShRNA).
Results: PC3 TP63-cells were viable but had a greatly reduced lifespan in
vitro. The PC3 TP63- injected mice only developed tumours after a sig-
niﬁcant delay compared to the PC3-2V groupwhich formed tumours at the
same rate as untransfected PC3 cells (around 21 days).
Conclusions: Knock down of p63 expression conﬁrmed that a minor
proportion of basal cells in PC3 possess the tumour initiation capacity.
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ABSTRACTSThus inhibition of p63-related signalling coupled with standard therapies
could result in a blockade of tumour progression, even in castrate resistant
prostate cancer where only limited therapeutic options are available.
SARS ACADEMIC AND RESEARCH PRIZE: 1159: PHOTOCHEMICAL INTER-
NALISATION AS A DELIVERY TOOL TO IMPROVE CHEMOTHERAPY FOR
ORAL SQUAMOUS CELL CARCINOMA
Ishita Basu, Alexander MacRobert, Colin Hopper. University College London,
London, UK.
Background & Aims: Photochemical internalisation (PCI) is based on
photodynamic therapy (PDT), and is a light-activated drug delivery tech-
nique that increases the bioavailability of therapeutic drugs through
photosensitised intracellular release of drugs entrapped within endocytic
vesicles. PCI reduces the toxicity in non-target tissues.
The aim of this study was to compare the cytotoxicity of PDT and PCI on an
oral squamous cell carcinoma cell line (HCPC-1) in vitro.
Method: The HCPC-1 cell line, developed from a hamster buccal pouch
carcinoma was used. The ribosome inactivating protein (RIP) toxin, sap-
orin, was used with the photosensitiser, disulfonated tetraphenylporphine
(TPPS2a). Blue light was used for PDT and combined with saporin for PCI.
Viability was assessed with the MTT assay.
Results: The PCI cytotoxicity was signiﬁcantly higher than PDT (P<
0.0001) and saporin (P < 0.0001) separately. The ratio to assess synergy A/
C x B, using cell viability, (A¼saporin, B¼PDT, C¼PCI) for HCPC-1 cells was
calculated to be 1.04, thus showing a PCI effect.
Conclusion: PCI is able to induce the relocalisation of saporin within cells
and therefore enhance cell death in HCPC-1 cells. PCI was also shown to be
signiﬁcantly more cytotoxic than PDT on the HCPC-1 oral cancer cell line.
SARS ACADEMIC AND RESEARCH PRIZE: 1423: A COMPARATIVE STUDY
OF THE PROGNOSTIC ROLE OF KI67 AND GEMININ IN BREAST CANCER
Sreekumar Sundara Rajan 1, Andrew Hanby 1, Kieran Horgan 1,
Valerie Speirs 2. 1 Leeds Teaching Hospitals NHS Trust, Leeds, UK; 2 Leeds
Institute of Molecular Medicine, University of Leeds, Leeds, UK.
Aims: Compared to other markers of cell proliferation, geminin is unique
being expressed selectively during the proliferative phase of the cell cycle.
We aimed to compare the prognostic signiﬁcance of geminin with that of
Ki67 and other common clinico-pathological variables.
Methods: Tissue microarrays containing 291 breast tumours were stained
using anti-geminin antibody (NCL-L; 1:12.5) and Ki67 (MIB1; 1:100).
Labelling index (LI) was calculated for geminin and the percentage of
positive cancer nuclei were determined for Ki67 expression. ROC curve
was used to determine the optimum cut-off value for geminin (LI  2) and
Ki67 ( 2.25%) for survival analysis.
Results: Geminin expression was positively correlated with Ki67 expres-
sion (r ¼ 0.686, p ¼ 0.001). Survival analysis showed poor BCSS and DFS
amongst cases positive for geminin [BCSS-HR 2.85 (1.53, 5.32); DFS-
HR¼2.63 (1.47, 4.71)] and Ki67 [BCSS-HR 2.62 (1.53, 4.48); DFS-HR 2.28
(1.39, 3.77)]. However on multivariate analysis, only geminin LI (DFS,
p¼0.04 (CI 1.01, 4.32); BCSS, p¼0.0003 (CI 1.79, 7.53)), nodal status, tumour
size and grade were found to be independent predictors.
Conclusions: In comparison to more established proliferation marker like
Ki67, geminin expression is a strong and independent predictor of adverse
outcome in breast cancer.
SARS ACADEMIC AND RESEARCH PRIZE: 1505: LOW NUCLEAR MAD2
EXPRESSION IS ASSOCIATED WITH OF LACK OF RESPONSE TO CHEMO-
THERAPY AND RADIOTHERAPY IN OESTROGEN RECEPTOR NEGATIVE
BREAST CANCER PATIENTS
Elma Anna O'Reilly 1, Shiva Sharma 1, Michele Harrison 3, Karolina Weiner-
Gorzel 1, Ciara Kelly 4, Aoife Maguire 5, Janet McCormack 6, Susie Conlon 3,
Susan Aherne 5, Caitlin Beggan 3, Richard Bambury 4, Tiffany Dorsey 7,
Stefan Ambs 7, Darran O'Connor 1, John McCaffrey 4, Reem Salman 2,
Sharon A. Glynn 8, Fiona Furlong 1, Amanda McCann 1, Malcolm Kell 2,
Cecily Quinn 1, Rut Klinger 1. 1UCD Conway Institute of Biomolecular &
Biomedical Research, School of Medicine & Medical Science, Belﬁeld, Dublin,
Ireland; 2Department of Surgery, Mater Misericordiae Hospital, Dublin, Ireland;
3Department of Pathology, Mater Misericordiae Hospital, Dublin, Ireland;
4Department of Oncology, Mater Misericordiae Hospital, Dublin, Ireland;
5Department of Pathology, St Vincents University Hospital, Dublin, Ireland;6Department of Digital Pathology Core Facility, The Conway Institute, Belﬁeld,
Dublin, Ireland; 7National Cancer Institute, Bethesda, Maryland, USA; 8 Prostate
Cancer Institute, NUI Galway, USA.
Introduction: Treatment options for TNBC are limited due to the lack of a
therapeutic target and are managed with standard chemotherapy such as
paclitaxel (Taxol(R)).
Decreased expression of the mitotic assembly deﬁcient protein (MAD2)
results in the induction of cellular senescence, demonstrable by enhanced
chemoresistance to paclitaxel (Taxol(R)). We hypothesize that low MAD2 is
predictive of poor response to chemotherapy.
Methods: 81 ER-negative tumours from an established US cohort were
assessed for MAD2 expression using immunohistochemistry. Kaplan-
Meier graphs and log-rank tests were used to display breast cancer sur-
vival. Proportional hazards cox regression was used to estimate hazard
ratios and conduct univariate and mutivariable analysis.
Results: Patients with high levels of MAD2 display increased breast cancer
speciﬁc survival (HRHighMAD2: 0.34, 95%CI 0.15-0.76, p¼0.008). Patients
with lowMAD2 do poorly. MAD2 prediction of outcome is limited to those
who received chemotherapy (Chemo: HRHighMAD2: 0.31, 95%CI 0.12-0.80,
p¼0.015; No chemo: HRHighMAD2: 1.03, 95%CI 0.10-10.6, p¼0.978), or
radiotherapy (Radiother: HRHighMAD2: 0.24, 95%CI 0.06-0.85, p¼0.027; No
radiother: HRHighMAD2: 0.48, 95%CI 0.15-1.51, p¼0.210). MAD2 expression is
predictive in patients who received both chemotherapy and radiotherapy
(HRHighMAD2: 0.09, 95%CI 0.02-0.45, p¼0.003).
Conclusion: We believe MAD2 is a predictor of poor outcome after
chemotherapy and radiotherapy in TNBC.ASIT SHORT PAPER PRIZE: 0044: THE USE OF ULTRASOUND FOR THE
ACUTE ABDOMEN IN THE SURGICAL ADMISSIONS UNIT (SAU)
Jana Torres-Grau, Richard Krysztopic. Royal United Hospital Bath, Bath, UK.
Objective: To improve the quality and efﬁciency of emergency surgical
services and reduce inpatient stay.
Introduction: Our surgical Admission Unit is a 27-bed-ward. When an
ultrasound is required, this is ordered to the radiology department. Time is
then spent prioritising the cases, and transferring the patient. We
hypothesised that a SAU based ultrasound would reduce time to diagnosis,
and consequently inpatient stay.
Methods: We had a 4-week period with a SAU-based radiographer, and
then a 4-week period of ultrasound performed in the radiology depart-
ment. Time to ultrasound, diagnosis and length of inpatient stay were
recorded and compared.
Results: Time to USS with ward based radiographer (group1) was 1hr 38
min compared to 36hr 25 min in the radiology department (group2) (p-
value 0.0001). The total inpatient-stay for group1 was 103hrs compared
with 159hrs for group2 (p-value 0.0001). A total of over 2 days less hos-
pital-stay for those who had an ultrasound while in SAU.
Conclusion: SAU based ultrasound hastens time to correct diagnosis,
treatment and or further investigations, and reduces the length of inpa-
tient stay, a mean of over 2 days. This is a signiﬁcant economical advantage
and improves the quality and efﬁciency of surgical emergency services,
being transferrable nationally.ASIT SHORT PAPER PRIZE: 0091: ASGBI/ASIT SHORT PAPER PRIZE
WINNER: FACTORS ASSOCIATED WITH MORTALITY WITHIN 1-YEAR
FOLLOWING A DISPLACED INTRACAPSULAR NECK OF FEMUR
FRACTURE
Maulik Gandhi, Swati Bhasin, Sohail Quraishi. Dudley Group of Hospitals,
Dudley, UK.
Introduction: Worldwide hip fracture incidence is projected to be 4.5
million by 2050. We analysed our hip fracture database to highlight factors
that (1) increased mortality within 1-year from admission; (2) correlate
with survival period.
Methods: Inclusions: Displaced intracapsular hip fractures between
August 2008 and July 2012. Exclusions: Admissions less than 1-year ago
and not reported deceased. Factors analysed: Nottingham Hip Fracture
Score (NHFS), age, admission haemoglobin (Hb), preadmission walking
ability outdoors, indoors (independent, one stick, two sticks or frame, bed/
wheelchair bound), gender and fracture side.
Results: Eligible patients ¼ 477. Signiﬁcance: NHFS (p < 0.001), age
(p¼0.0000), Hb result (p¼0.0019), walking ability outdoors (p< 0.001),
